Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Sigmann, P.
space
 arrow  PubMed                        
space

LETTER

Minocycline-induced Pneumonia

right arrow Peter Sigmann

1 May 1993 | Volume 118 Issue 9 | Pages 749-750


TO THE EDITOR:

Guillon and colleagues [1] evaluated the mechanism of hypersensitivity pneumonitis after exposure and re-exposure to minocycline in a patient with chronic lung disease. We saw a similar phenomenon in 1986 in a 17-year-old woman without chronic lung disease. She experienced progressively severe pulmonary and extrapulmonary reactions to exposure and inadvertent re-exposures to minocycline.

The patient had taken minocycline, 100 mg/d, for 18 months to control acne vulgaris. In childhood, she had been treated for myasthenia gravis, and the disease had been in remission for 5 years. A nonproductive cough began 4 weeks before evaluation, and a sore throat accompanied by fever began 1 week before the patient's visit. Exertional dyspnea, aching limbs, and intensified cough developed. Findings included nonexudative pharyngitis, a tender forearm and wrist with no signs of synovitis, physical findings of lung consolidation bilaterally, and radiologic evidence of patchy infiltrate with volume loss in the lower lobes and of small pleural effusions. The symptoms cleared, and a clinical lung examination was normal after a 2-week course of erythromycin, during which she took no minocycline.

The illness "relapsed" three times until the relation to minocycline became evident. On each occasion, challenge with a single 100-mg dose of minocycline was followed within 1 to 2 hours by shaking chills, a temperature of up to 40 °C, and, at the final occurrence, hypotension. All symptoms cleared during abstinence from minocycline. The total and differential leukocyte counts remained normal. The alanine aminotransferase level was elevated during relapses, with a maximum of 396 U/L (normal, 0 to 38 U/L). The highest observed {gamma}-glutamyltransferase level was 71 U/L (normal, 0 to 36 U/L). Cryoglobulin, anti-DNA, anti-SCL70 antibodies, antibodies to extractable nuclear antigens, and rheumatoid factor were absent or normal. The antinuclear antibody titer was 1:640 with a nucleolar fluorescence pattern.

In this case, hypersensitivity developed only after prolonged exposure to minocycline, possibly triggered by a respiratory infection, and was specific to minocycline, not to tetracycline. Liver toxicity was apparent. Except for the absence of eosinophilia, this case is similar to three cases reported in the literature [2, 3]. Previous autoimmune disease suggests that this patient may have been predisposed to this reaction.


References
space
up arrowTop
dotReferences

1. Guillon JM, Joly P, Autran B, Denis M, Akoun G, Debre P, et al. Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med. 1992; 117:476-81.

2. Kuroki H, Usami I, Hanaki H. A case of minocycline-induced pneumonitis. Nippon Kyobu Shikkan Gakkai Zasshi. 1986; 24:553-7.

3. Ho D, Tashkin DP, Bein ME, Sharma O. Pulmonary infiltrates with eosinophilia associated with tetracycline. Chest. 1979; 76:33-4.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Sigmann, P.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online